Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedPal AILSE:MPAL Gross Margin % is 23.00% as of Feb. 2026. The stock has 1 warning sign investors should review. Among 627 Healthcare Providers & Services companies, MedPal AI ranks worse than 78.79% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. MedPal AI's Gross Profit for the
six
months ended in Feb. 2026 was £0.37 Mil. MedPal AI's Revenue for the
six
months ended in Feb. 2026 was £1.60 Mil. Therefore, MedPal AI's Gross Margin % for the quarter that ended in Feb. 2026 was 23.00%.
The historical rank and industry rank for MedPal AI's Gross Margin % or its related term are showing as below:
LSE:MPAL'
s Gross Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 23.01
Current: 23.01
During the past 4 years, the highestGross Margin % of MedPal AI was 23.01%. The lowest was 0.00%. And the median was 0.00%.
LSE:MPAL's Gross Margin % is ranked worse than 78.79% of 627
companies
in the Healthcare Providers & Services industry
Industry Median: 40.06
vs LSE:MPAL: 23.01
MedPal AI had a gross margin of 23.00% for the quarter that ended in Feb. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for MedPal AI was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
MedPal AI had a gross margin of 23.00% for the quarter that ended in Feb. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
MedPal AI Gross Margin % Related Terms
MedPal AI Gross Margin % Historical Data
* Premium members only.
The historical data trend for MedPal AI's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:MPAL vs VEEV, BTSG, HQY: Gross Margin % Comparison
For the Health Information Services subindustry, MedPal AI's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedPal AI Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's Gross Margin % distribution charts can be found below:
* The bar in red indicates where MedPal AI's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
MedPal AI (LSE:MPAL) has a Gross Margin % of 23.00% as of Feb. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on MedPal AI and its competitors. According to the industry distribution chart, MedPal AI ranks #494 out of 627 companies in the Healthcare Providers & Services industry, placing it in the top 78.8%.
Is MedPal AI's Gross Margin % too high?
MedPal AI's current Gross Margin % is 23.00%. The Healthcare Providers & Services industry median Gross Margin % is 40.06. MedPal AI's value of 23.00% is 42.6% below this industry median. Based on the distribution chart, MedPal AI ranks #494 out of 627 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does MedPal AI's Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedPal AI ranks #494 out of 627 companies for Gross Margin %. This places MedPal AI in the lower half of its industry. The industry median Gross Margin % is 40.06. MedPal AI's value of 23.00% is 42.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.06, based on 627 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedPal AI's current Gross Margin % of 23.00% is 42.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on MedPal AI and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedPal AI's current Gross Margin % is 23.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current Gross Margin % of 23.00%. The current Gross Margin % is 23.00% and 42.6% below the Healthcare Providers & Services industry median of 40.06. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current Gross Margin % is 23.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:MPAL has been successfully added to your 
